Back

Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation

Maison, D. P.; Ching, L. L.; Shikuma, C. M.; Nerurkar, V. R.

2021-01-07 evolutionary biology
10.1101/2021.01.06.425497 bioRxiv
Show abstract

COVID-19 pandemic has ravaged the world, caused over 1.8 million deaths in the first year, and severely affected the global economy. Hawaii is not spared from the transmission of SARS-CoV-2 in the local population, including high infection rates in racial and ethnic minorities. Early in the pandemic, we described in this journal various technologies used for the detection of SARS-CoV-2. Herein we characterize a 969-bp SARS-CoV-2 segment of the S gene downstream of the receptor-binding domain. At the John A. Burns School of Medicine Biocontainment Facility, RNA was extracted from an oropharyngeal swab and a nasal swab from two patients from Hawaii who were infected with the SARS-CoV-2 in August 2020. Following PCR, the two viral strains were sequenced using Sanger sequencing, and phylogenetic trees were generated using MEGAX. Phylogenetic tree results indicate that the virus has been introduced to Hawaii from multiple sources. Further, we decoded 13 single nucleotide polymorphisms across 13 unique SARS-CoV-2 genomes within this region of the S gene, with one non-synonymous mutation (P681H) found in the two Hawaii strains. The P681H mutation has unique and emerging characteristics with a significant exponential increase in worldwide frequency when compared to the plateauing of the now universal D614G mutation. The P681H mutation is also characteristic of the new SARS-CoV-2 variants from the United Kingdom and Nigeria. Additionally, several mutations resulting in cysteine residues were detected, potentially resulting in disruption of the disulfide bridges in and around the receptor-binding domain. Targeted sequence characterization is warranted to determine the origin of multiple introductions of SARS-CoV-2 circulating in Hawaii.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 11%
17.6%
2
Journal of Medical Virology
137 papers in training set
Top 0.1%
10.1%
3
Medical Research Archives
11 papers in training set
Top 0.1%
7.2%
4
Viruses
318 papers in training set
Top 1%
4.9%
5
Scientific Reports
3102 papers in training set
Top 36%
3.6%
6
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.2%
3.1%
7
PLOS Pathogens
721 papers in training set
Top 4%
2.7%
8
Genes
126 papers in training set
Top 0.6%
2.1%
50% of probability mass above
9
PeerJ
261 papers in training set
Top 6%
1.9%
10
Frontiers in Genetics
197 papers in training set
Top 4%
1.8%
11
Infection, Genetics and Evolution
43 papers in training set
Top 0.3%
1.8%
12
Science Bulletin
22 papers in training set
Top 0.3%
1.7%
13
mBio
750 papers in training set
Top 7%
1.7%
14
Emerging Microbes & Infections
74 papers in training set
Top 1.0%
1.5%
15
Frontiers in Microbiology
375 papers in training set
Top 6%
1.5%
16
Microbiology Spectrum
435 papers in training set
Top 3%
1.5%
17
iScience
1063 papers in training set
Top 18%
1.5%
18
Virology
56 papers in training set
Top 0.4%
1.5%
19
eLife
5422 papers in training set
Top 47%
1.3%
20
BMC Ecology and Evolution
49 papers in training set
Top 1%
1.2%
21
International Journal of Biological Macromolecules
65 papers in training set
Top 2%
1.2%
22
Pathogens
53 papers in training set
Top 1.0%
1.1%
23
National Science Review
22 papers in training set
Top 2%
0.9%
24
Journal of Genetics and Genomics
36 papers in training set
Top 2%
0.8%
25
Frontiers in Medicine
113 papers in training set
Top 6%
0.8%
26
Journal of Virology
456 papers in training set
Top 3%
0.8%
27
Microbial Genomics
204 papers in training set
Top 2%
0.7%
28
F1000Research
79 papers in training set
Top 5%
0.7%
29
mSystems
361 papers in training set
Top 8%
0.7%
30
Science China Life Sciences
26 papers in training set
Top 2%
0.7%